ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661581 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661581; 2) Community: the network communities that were significantly associated with the response to NSC 661581; 3) Molecule: the relationships between components within communities and NSC 661581; 4) MDR: the compounds that were significantly associated with the NSC 661581.

NSC Compound Enrichment Correlation
NSC 44684 Null 0.00627320055153809 0.41265743
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.00627320055153812 0.36588476
NSC 672058 Null 0.00627320055153812 0.5513549
NSC 681632 Camptothecin Derivative 0.00627320055153812 0.057372188
NSC 684118 Pyrido[3,4-g]quinoline-5,10-dione, 1,4-dihydro- 1-(dimethylamino)-4-methyl- 0.00627320055153812 0.10720152
NSC 278632 Null 0.00741876119839025 0.44619911
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.00741876119839025 0.72333823
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.00741876119839025 0.50921521
NSC 622282 4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- 0.00741876119839025 0.74150371
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.00741876119839025 0.49252767
Total:64  Current:10    [First] [Prev] [Next] [Last]